Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
EGX | peptech merger | 15/05/07 | 7 | 2.7K | |||
|
|||||||
EGX | 1.12 offer but sell still at 84.5c | 07/05/07 | 1 | 733 | |||
|
|||||||
EGX | peptech merger | 07/05/07 | 0 | 439 | |||
|
|||||||
EGX | flying under the radar | 05/05/07 | 4 | 1.8K | |||
|
|||||||
EGX | to collaborate with nih | 09/11/06 | 3 | 1.6K | |||
|
|||||||
EGX | next big biotech | 12:16 | 3 | 1.2K | |||
|
|||||||
EGX | big volume | 11/08/06 | 0 | 408 | |||
|
|||||||
EGX | resignation of company secretary | 09/06/06 | 1 | 623 | |||
|
See All Discussions